Personalis, Inc. - 8-K Filing
On May 19, 2026, Medicare expanded coverage for Personalis' NeXT Personal® test to include monitoring treatment response in patients with Stage II-III Triple-Negative Breast Cancer or HER2-positive breast cancer undergoing neoadjuvant therapy. (Items: 8.01 Other Events)
Tickers: $PSNL